NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|446136697|ref|WP_000214552|]
View 

MULTISPECIES: ketol-acid reductoisomerase [Staphylococcus]

Protein Classification

NADP-dependent ketol-acid reductoisomerase( domain architecture ID 11481043)

NADP-dependent ketol-acid reductoisomerase catalyzes the conversion of 2-(S)-acetolactate (2SAL) into (R)-dihydroxyisovalerate (RDHIV), the second step in the biosynthesis of the branched-chain amino acids (BCAAs) valine, leucine and isoleucine

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PRK05479 PRK05479
ketol-acid reductoisomerase; Provisional
1-329 0e+00

ketol-acid reductoisomerase; Provisional


:

Pssm-ID: 235491 [Multi-domain]  Cd Length: 330  Bit Score: 639.83  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   1 MTTVYYDQDVKTDALQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPG-RSFDKAKEDGFDVFPVAEAVKQADVIMVL 79
Cdd:PRK05479   1 MMKVYYDKDADLSLIKGKKVAIIGYGSQGHAHALNLRDSGVDVVVGLREGsKSWKKAEADGFEVLTVAEAAKWADVIMIL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  80 LPDEIQGDVYKNEIEPNLEKHNALAFAHGFNIHFGVIQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGIQQDASGQ 159
Cdd:PRK05479  81 LPDEVQAEVYEEEIEPNLKEGAALAFAHGFNIHFGQIVPPADVDVIMVAPKGPGHLVRREYEEGGGVPCLIAVHQDASGN 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 160 ARNIALSYAKGIGATRAGVIETTFKEETETDLFGEQAVLCGGVSKLIQSGFETLVEAGYQPELAYFEVLHEMKLIVDLMY 239
Cdd:PRK05479 161 AKDLALAYAKGIGGTRAGVIETTFKEETETDLFGEQAVLCGGLTELIKAGFETLVEAGYQPEMAYFECLHELKLIVDLIY 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 240 EGGMENVRYSISNTAEFGDYVSGPRVITPDVKENMKAVLTDIQNGNFSNRFIEDNKNGFKEFYKLREEQHGHQIEKVGRE 319
Cdd:PRK05479 241 EGGIANMRYSISNTAEYGDYVSGPRVITEETKKEMKEVLKDIQSGEFAKEWILENKAGRPTFKALRREEAEHPIEKVGAK 320
                        330
                 ....*....|
gi 446136697 320 LREMMPFIKS 329
Cdd:PRK05479 321 LRAMMPWIKK 330
 
Name Accession Description Interval E-value
PRK05479 PRK05479
ketol-acid reductoisomerase; Provisional
1-329 0e+00

ketol-acid reductoisomerase; Provisional


Pssm-ID: 235491 [Multi-domain]  Cd Length: 330  Bit Score: 639.83  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   1 MTTVYYDQDVKTDALQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPG-RSFDKAKEDGFDVFPVAEAVKQADVIMVL 79
Cdd:PRK05479   1 MMKVYYDKDADLSLIKGKKVAIIGYGSQGHAHALNLRDSGVDVVVGLREGsKSWKKAEADGFEVLTVAEAAKWADVIMIL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  80 LPDEIQGDVYKNEIEPNLEKHNALAFAHGFNIHFGVIQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGIQQDASGQ 159
Cdd:PRK05479  81 LPDEVQAEVYEEEIEPNLKEGAALAFAHGFNIHFGQIVPPADVDVIMVAPKGPGHLVRREYEEGGGVPCLIAVHQDASGN 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 160 ARNIALSYAKGIGATRAGVIETTFKEETETDLFGEQAVLCGGVSKLIQSGFETLVEAGYQPELAYFEVLHEMKLIVDLMY 239
Cdd:PRK05479 161 AKDLALAYAKGIGGTRAGVIETTFKEETETDLFGEQAVLCGGLTELIKAGFETLVEAGYQPEMAYFECLHELKLIVDLIY 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 240 EGGMENVRYSISNTAEFGDYVSGPRVITPDVKENMKAVLTDIQNGNFSNRFIEDNKNGFKEFYKLREEQHGHQIEKVGRE 319
Cdd:PRK05479 241 EGGIANMRYSISNTAEYGDYVSGPRVITEETKKEMKEVLKDIQSGEFAKEWILENKAGRPTFKALRREEAEHPIEKVGAK 320
                        330
                 ....*....|
gi 446136697 320 LREMMPFIKS 329
Cdd:PRK05479 321 LRAMMPWIKK 330
IlvC COG0059
Ketol-acid reductoisomerase [Amino acid transport and metabolism, Coenzyme transport and ...
1-327 0e+00

Ketol-acid reductoisomerase [Amino acid transport and metabolism, Coenzyme transport and metabolism]; Ketol-acid reductoisomerase is part of the Pathway/BioSystem: Isoleucine, leucine, valine biosynthesis


Pssm-ID: 439829 [Multi-domain]  Cd Length: 328  Bit Score: 619.77  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   1 MTTVYYDQDVKTDALQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPGR-SFDKAKEDGFDVFPVAEAVKQADVIMVL 79
Cdd:COG0059    1 MAKIYYDKDADLSLLKGKKVAVIGYGSQGHAHALNLRDSGVDVVVGLREGSkSWKKAEEDGFEVMTVAEAAKRADVIMIL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  80 LPDEIQGDVYKNEIEPNLEKHNALAFAHGFNIHFGVIQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGIQQDASGQ 159
Cdd:COG0059   81 TPDEVQAAVYEEEIAPNLKPGAALAFAHGFNIHFGQIVPPADVDVIMVAPKGPGHLVRREYEEGFGVPALIAVHQDATGK 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 160 ARNIALSYAKGIGATRAGVIETTFKEETETDLFGEQAVLCGGVSKLIQSGFETLVEAGYQPELAYFEVLHEMKLIVDLMY 239
Cdd:COG0059  161 AKDLALAYAKGIGGTRAGVIETTFKEETETDLFGEQAVLCGGLTALIKAGFETLVEAGYQPEMAYFECLHELKLIVDLIY 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 240 EGGMENVRYSISNTAEFGDYVSGPRVITPDVKENMKAVLTDIQNGNFSNRFIEDNKNGFKEFYKLREEQHGHQIEKVGRE 319
Cdd:COG0059  241 EGGIANMRYSISNTAEYGDYTRGPRVITEEVKEEMKKVLDDIQSGEFAKEWILENQAGRPNLNALRAEEAEHPIEKVGAE 320

                 ....*...
gi 446136697 320 LREMMPFI 327
Cdd:COG0059  321 LRAMMPWL 328
ilvC TIGR00465
ketol-acid reductoisomerase; This is the second enzyme in the parallel isoleucine-valine ...
15-328 1.81e-152

ketol-acid reductoisomerase; This is the second enzyme in the parallel isoleucine-valine biosynthetic pathway [Amino acid biosynthesis, Pyruvate family]


Pssm-ID: 273093 [Multi-domain]  Cd Length: 314  Bit Score: 430.65  E-value: 1.81e-152
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   15 LQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPG-RSFDKAKEDGFDVFPVAEAVKQADVIMVLLPDEIQGDVYKNEI 93
Cdd:TIGR00465   1 LKGKTVAIIGYGSQGHAQALNLRDSGLNVIVGLRKGgASWKKATEDGFKVGTVEEAIPQADLIMNLLPDEVQHEVYEAEI 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   94 EPNLEKHNALAFAHGFNIHFGVIQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGIQQDASGQARNIALSYAKGIGA 173
Cdd:TIGR00465  81 QPLLKEGKTLGFSHGFNIHFVQIVPPKDVDVVMVAPKGPGTLVREEYKEGFGVPTLIAVEQDPTGEAMAIALAYAKAIGG 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  174 TRAGVIETTFKEETETDLFGEQAVLCGGVSKLIQSGFETLVEAGYQPELAYFEVLHEMKLIVDLMYEGGMENVRYSISNT 253
Cdd:TIGR00465 161 GRAGVLETTFKEETESDLFGEQAVLCGGLTALIKAGFDTLVEAGYQPELAYFETVHELKLIVDLIYEGGITGMRDRISNT 240
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 446136697  254 AEFGDYVSGpRVITPDVKENMKAVLTDIQNGNFSNRFIEDNKNGFKEFYKLREEQHGHQIEKVGRELREMMPFIK 328
Cdd:TIGR00465 241 AEYGALTRR-RIIKEELKPEMQKILKEIQNGEFAKEWALENEAGKPAFNTARKYESEHEIEKVGKELRAMVPAGK 314
IlvN pfam07991
Acetohydroxy acid isomeroreductase, NADPH-binding domain; Acetohydroxy acid isomeroreductase ...
14-177 1.59e-105

Acetohydroxy acid isomeroreductase, NADPH-binding domain; Acetohydroxy acid isomeroreductase catalyzes the conversion of acetohydroxy acids into dihydroxy valerates. This reaction is the second in the synthetic pathway of the essential branched side chain amino acids valine and isoleucine. This N-terminal region of the enzyme carries the binding-site for NADPH. The active-site for enzymatic activity lies in the C-terminal part, IlvC, pfam01450.


Pssm-ID: 285265  Cd Length: 165  Bit Score: 305.62  E-value: 1.59e-105
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   14 ALQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPG-RSFDKAKEDGFDVFPVAEAVKQADVIMVLLPDEIQGDVYKNE 92
Cdd:pfam07991   1 VLKGKKIAVIGYGSQGHAHALNLRDSGVNVIVGLREGsKSWKKAKKDGFEVYTVAEAAKKADVIMILIPDEVQAEVYEEE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   93 IEPNLEKHNALAFAHGFNIHFGVIQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGIQQDASGQARNIALSYAKGIG 172
Cdd:pfam07991  81 IAPNLKEGAALAFAHGFNIHFGQIKPPKDVDVIMVAPKGPGHLVRREYEEGGGVPALIAVHQDASGKAKDLALAYAKGIG 160

                  ....*
gi 446136697  173 ATRAG 177
Cdd:pfam07991 161 GTRAG 165
PGDH_1 cd12155
Phosphoglycerate Dehydrogenase, 2-hydroxyacid dehydrogenase family; Phosphoglycerate ...
6-81 1.86e-05

Phosphoglycerate Dehydrogenase, 2-hydroxyacid dehydrogenase family; Phosphoglycerate Dehydrogenase (PGDH) catalyzes the NAD-dependent conversion of 3-phosphoglycerate into 3-phosphohydroxypyruvate, which is the first step in serine biosynthesis. Over-expression of PGDH has been implicated as supporting proliferation of certain breast cancers, while PGDH deficiency is linked to defects in mammalian central nervous system development. PGDH is a member of the 2-hydroxyacid dehydrogenase family, enzymes that catalyze the conversion of a wide variety of D-2-hydroxy acids to their corresponding keto acids. The general mechanism is (R)-lactate + acceptor to pyruvate + reduced acceptor. Formate/glycerate and related dehydrogenases of the D-specific 2-hydroxyacid dehydrogenase superfamily include groups such as formate dehydrogenase, glycerate dehydrogenase, L-alanine dehydrogenase, and S-Adenosylhomocysteine Hydrolase. Despite often low sequence identity, these proteins typically have a characteristic arrangement of 2 similar subdomains of the alpha/beta Rossmann-fold NAD+ binding form. The NAD+ binding domain is inserted within the linear sequence of the mostly N-terminal catalytic domain, which has a similar domain structure to the internal NAD binding domain. Structurally, these domains are connected by extended alpha helices and create a cleft in which NAD is bound, primarily to the C-terminal portion of the 2nd (internal) domain. Some related proteins have similar structural subdomain but with a tandem arrangement of the catalytic and NAD-binding subdomains in the linear sequence. While many members of this family are dimeric, alanine DH is hexameric and phosphoglycerate DH is tetrameric.


Pssm-ID: 240632 [Multi-domain]  Cd Length: 314  Bit Score: 45.65  E-value: 1.86e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   6 YDQDVKTDALQGKKIAVVGYGSQGHAHAQNLKdnGYDV-VIGI-RPGRsfdkaKEDGFD-VFP---VAEAVKQADVIMVL 79
Cdd:cd12155  124 WKMDSSLLELYGKTILFLGTGSIGQEIAKRLK--AFGMkVIGVnTSGR-----DVEYFDkCYPleeLDEVLKEADIVVNV 196

                 ..
gi 446136697  80 LP 81
Cdd:cd12155  197 LP 198
AdoHcyase_NAD smart00997
S-adenosyl-L-homocysteine hydrolase, NAD binding domain;
15-76 2.49e-04

S-adenosyl-L-homocysteine hydrolase, NAD binding domain;


Pssm-ID: 198065 [Multi-domain]  Cd Length: 162  Bit Score: 40.90  E-value: 2.49e-04
                           10        20        30        40        50        60
                   ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 446136697    15 LQGKKIAVVGYGSQGHAHAQNLKDNGYDV-VIGIRPGRSFdKAKEDGFDVFPVAEAVKQADVI 76
Cdd:smart00997  21 LAGKNVVVAGYGDVGKGVAARLRGLGARViVTEIDPIRAL-EAAMDGFEVMKMEEAAKRADIF 82
 
Name Accession Description Interval E-value
PRK05479 PRK05479
ketol-acid reductoisomerase; Provisional
1-329 0e+00

ketol-acid reductoisomerase; Provisional


Pssm-ID: 235491 [Multi-domain]  Cd Length: 330  Bit Score: 639.83  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   1 MTTVYYDQDVKTDALQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPG-RSFDKAKEDGFDVFPVAEAVKQADVIMVL 79
Cdd:PRK05479   1 MMKVYYDKDADLSLIKGKKVAIIGYGSQGHAHALNLRDSGVDVVVGLREGsKSWKKAEADGFEVLTVAEAAKWADVIMIL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  80 LPDEIQGDVYKNEIEPNLEKHNALAFAHGFNIHFGVIQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGIQQDASGQ 159
Cdd:PRK05479  81 LPDEVQAEVYEEEIEPNLKEGAALAFAHGFNIHFGQIVPPADVDVIMVAPKGPGHLVRREYEEGGGVPCLIAVHQDASGN 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 160 ARNIALSYAKGIGATRAGVIETTFKEETETDLFGEQAVLCGGVSKLIQSGFETLVEAGYQPELAYFEVLHEMKLIVDLMY 239
Cdd:PRK05479 161 AKDLALAYAKGIGGTRAGVIETTFKEETETDLFGEQAVLCGGLTELIKAGFETLVEAGYQPEMAYFECLHELKLIVDLIY 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 240 EGGMENVRYSISNTAEFGDYVSGPRVITPDVKENMKAVLTDIQNGNFSNRFIEDNKNGFKEFYKLREEQHGHQIEKVGRE 319
Cdd:PRK05479 241 EGGIANMRYSISNTAEYGDYVSGPRVITEETKKEMKEVLKDIQSGEFAKEWILENKAGRPTFKALRREEAEHPIEKVGAK 320
                        330
                 ....*....|
gi 446136697 320 LREMMPFIKS 329
Cdd:PRK05479 321 LRAMMPWIKK 330
IlvC COG0059
Ketol-acid reductoisomerase [Amino acid transport and metabolism, Coenzyme transport and ...
1-327 0e+00

Ketol-acid reductoisomerase [Amino acid transport and metabolism, Coenzyme transport and metabolism]; Ketol-acid reductoisomerase is part of the Pathway/BioSystem: Isoleucine, leucine, valine biosynthesis


Pssm-ID: 439829 [Multi-domain]  Cd Length: 328  Bit Score: 619.77  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   1 MTTVYYDQDVKTDALQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPGR-SFDKAKEDGFDVFPVAEAVKQADVIMVL 79
Cdd:COG0059    1 MAKIYYDKDADLSLLKGKKVAVIGYGSQGHAHALNLRDSGVDVVVGLREGSkSWKKAEEDGFEVMTVAEAAKRADVIMIL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  80 LPDEIQGDVYKNEIEPNLEKHNALAFAHGFNIHFGVIQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGIQQDASGQ 159
Cdd:COG0059   81 TPDEVQAAVYEEEIAPNLKPGAALAFAHGFNIHFGQIVPPADVDVIMVAPKGPGHLVRREYEEGFGVPALIAVHQDATGK 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 160 ARNIALSYAKGIGATRAGVIETTFKEETETDLFGEQAVLCGGVSKLIQSGFETLVEAGYQPELAYFEVLHEMKLIVDLMY 239
Cdd:COG0059  161 AKDLALAYAKGIGGTRAGVIETTFKEETETDLFGEQAVLCGGLTALIKAGFETLVEAGYQPEMAYFECLHELKLIVDLIY 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 240 EGGMENVRYSISNTAEFGDYVSGPRVITPDVKENMKAVLTDIQNGNFSNRFIEDNKNGFKEFYKLREEQHGHQIEKVGRE 319
Cdd:COG0059  241 EGGIANMRYSISNTAEYGDYTRGPRVITEEVKEEMKKVLDDIQSGEFAKEWILENQAGRPNLNALRAEEAEHPIEKVGAE 320

                 ....*...
gi 446136697 320 LREMMPFI 327
Cdd:COG0059  321 LRAMMPWL 328
ilvC TIGR00465
ketol-acid reductoisomerase; This is the second enzyme in the parallel isoleucine-valine ...
15-328 1.81e-152

ketol-acid reductoisomerase; This is the second enzyme in the parallel isoleucine-valine biosynthetic pathway [Amino acid biosynthesis, Pyruvate family]


Pssm-ID: 273093 [Multi-domain]  Cd Length: 314  Bit Score: 430.65  E-value: 1.81e-152
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   15 LQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPG-RSFDKAKEDGFDVFPVAEAVKQADVIMVLLPDEIQGDVYKNEI 93
Cdd:TIGR00465   1 LKGKTVAIIGYGSQGHAQALNLRDSGLNVIVGLRKGgASWKKATEDGFKVGTVEEAIPQADLIMNLLPDEVQHEVYEAEI 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   94 EPNLEKHNALAFAHGFNIHFGVIQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGIQQDASGQARNIALSYAKGIGA 173
Cdd:TIGR00465  81 QPLLKEGKTLGFSHGFNIHFVQIVPPKDVDVVMVAPKGPGTLVREEYKEGFGVPTLIAVEQDPTGEAMAIALAYAKAIGG 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  174 TRAGVIETTFKEETETDLFGEQAVLCGGVSKLIQSGFETLVEAGYQPELAYFEVLHEMKLIVDLMYEGGMENVRYSISNT 253
Cdd:TIGR00465 161 GRAGVLETTFKEETESDLFGEQAVLCGGLTALIKAGFDTLVEAGYQPELAYFETVHELKLIVDLIYEGGITGMRDRISNT 240
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 446136697  254 AEFGDYVSGpRVITPDVKENMKAVLTDIQNGNFSNRFIEDNKNGFKEFYKLREEQHGHQIEKVGRELREMMPFIK 328
Cdd:TIGR00465 241 AEYGALTRR-RIIKEELKPEMQKILKEIQNGEFAKEWALENEAGKPAFNTARKYESEHEIEKVGKELRAMVPAGK 314
PRK13403 PRK13403
ketol-acid reductoisomerase; Provisional
5-328 4.92e-145

ketol-acid reductoisomerase; Provisional


Pssm-ID: 106361 [Multi-domain]  Cd Length: 335  Bit Score: 412.60  E-value: 4.92e-145
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   5 YYDQDVKTDALQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPGRSFDKAKEDGFDVFPVAEAVKQADVIMVLLPDEI 84
Cdd:PRK13403   4 YYEKDANVELLQGKTVAVIGYGSQGHAQAQNLRDSGVEVVVGVRPGKSFEVAKADGFEVMSVSEAVRTAQVVQMLLPDEQ 83
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  85 QGDVYKNEIEPNLEKHNALAFAHGFNIHFGVIQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGIQQDASGQARNIA 164
Cdd:PRK13403  84 QAHVYKAEVEENLREGQMLLFSHGFNIHFGQINPPSYVDVAMVAPKSPGHLVRRVFQEGNGVPALVAVHQDATGTALHVA 163
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 165 LSYAKGIGATRAGVIETTFKEETETDLFGEQAVLCGGVSKLIQSGFETLVEAGYQPELAYFEVLHEMKLIVDLMYEGGME 244
Cdd:PRK13403 164 LAYAKGVGCTRAGVIETTFQEETETDLFGEQAVLCGGVTALVKAGFETLTEGGYRPEIAYFECLHELKLIVDLMYEGGLT 243
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 245 NVRYSISNTAEFGDYVSGPRVITPDVKENMKAVLTDIQNGNFSNRFIEDNKNGFKEFYKLREEQHGHQIEKVGRELREMM 324
Cdd:PRK13403 244 NMRHSISDTAEFGDYVTGSRIVTDETKKEMKRVLTEIQQGEFAKKWILENQAGRPTYNAMKKAEQNHQLEKVGEELREMM 323

                 ....
gi 446136697 325 PFIK 328
Cdd:PRK13403 324 SWIH 327
IlvN pfam07991
Acetohydroxy acid isomeroreductase, NADPH-binding domain; Acetohydroxy acid isomeroreductase ...
14-177 1.59e-105

Acetohydroxy acid isomeroreductase, NADPH-binding domain; Acetohydroxy acid isomeroreductase catalyzes the conversion of acetohydroxy acids into dihydroxy valerates. This reaction is the second in the synthetic pathway of the essential branched side chain amino acids valine and isoleucine. This N-terminal region of the enzyme carries the binding-site for NADPH. The active-site for enzymatic activity lies in the C-terminal part, IlvC, pfam01450.


Pssm-ID: 285265  Cd Length: 165  Bit Score: 305.62  E-value: 1.59e-105
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   14 ALQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPG-RSFDKAKEDGFDVFPVAEAVKQADVIMVLLPDEIQGDVYKNE 92
Cdd:pfam07991   1 VLKGKKIAVIGYGSQGHAHALNLRDSGVNVIVGLREGsKSWKKAKKDGFEVYTVAEAAKKADVIMILIPDEVQAEVYEEE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   93 IEPNLEKHNALAFAHGFNIHFGVIQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGIQQDASGQARNIALSYAKGIG 172
Cdd:pfam07991  81 IAPNLKEGAALAFAHGFNIHFGQIKPPKDVDVIMVAPKGPGHLVRREYEEGGGVPALIAVHQDASGKAKDLALAYAKGIG 160

                  ....*
gi 446136697  173 ATRAG 177
Cdd:pfam07991 161 GTRAG 165
IlvC pfam01450
Acetohydroxy acid isomeroreductase, catalytic domain; Acetohydroxy acid isomeroreductase ...
190-321 5.54e-80

Acetohydroxy acid isomeroreductase, catalytic domain; Acetohydroxy acid isomeroreductase catalyzes the conversion of acetohydroxy acids into dihydroxy valerates. This reaction is the second in the synthetic pathway of the essential branched side chain amino acids valine and isoleucine.


Pssm-ID: 460215 [Multi-domain]  Cd Length: 138  Bit Score: 239.68  E-value: 5.54e-80
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  190 DLFGEQAVLCGGVSKLIQSGFETLVEAGYQPELAYFEVLHEMKLIVDLMYEGGMENVRYSISNTAEFGDYVSGPRVITPD 269
Cdd:pfam01450   7 DLFGEQAVLCGGVTGLVKAGFETLVEAGYQPEAAYFECLHELKLIVDLIYEGGIAGMRYSISDTAEYGDLTRGPRVIYDA 86
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|..
gi 446136697  270 VKENMKAVLTDIQNGNFSNRFIEDNKNGFKEFYKLREEQHGHQIEKVGRELR 321
Cdd:pfam01450  87 TKELMKEILDEIQSGEFAKEWILEYQAGRPELKALRREEAEHPIEKVGKELR 138
PRK05225 PRK05225
ketol-acid reductoisomerase; Validated
13-307 1.66e-42

ketol-acid reductoisomerase; Validated


Pssm-ID: 235368 [Multi-domain]  Cd Length: 487  Bit Score: 153.19  E-value: 1.66e-42
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  13 DALQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPG------RSFDKAKEDGFDVFPVAEAVKQADVIMVLLPDEIQG 86
Cdd:PRK05225  32 SYLKGKKIVIVGCGAQGLNQGLNMRDSGLDISYALRKEaiaekrASWRKATENGFKVGTYEELIPQADLVINLTPDKQHS 111
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  87 DVYkNEIEPNLEKHNALAFAHGFNI-HFGViQPPADVDVFLVAPKGPGHLVRRTFVEGSAVPSLFGI--QQDASGQARNI 163
Cdd:PRK05225 112 DVV-RAVQPLMKQGAALGYSHGFNIvEVGE-QIRKDITVVMVAPKCPGTEVREEYKRGFGVPTLIAVhpENDPKGEGMAI 189
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697 164 ALSYAKGIGATRAGVIETTFKEETETDLFGEQAVLCGgvskLIQSG----FETLVEAGYQPELAYFEVLHEMKLIVDLMY 239
Cdd:PRK05225 190 AKAWAAATGGHRAGVLESSFVAEVKSDLMGEQTILCG----MLQAGsllcFDKLVAEGTDPAYAEKLIQFGWETITEALK 265
                        250       260       270       280       290       300       310
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 446136697 240 EGGMENVRYSISNTAEFGDYvsgprvitpDVKENMKAVLT--------DIQNGNFSNRFIEDNKNGFKEFYKLREE 307
Cdd:PRK05225 266 QGGITLMMDRLSNPAKIRAF---------ELSEQLKEIMAplfqkhmdDIISGEFSSTMMADWANDDKKLLTWREE 332
NAD_binding_2 pfam03446
NAD binding domain of 6-phosphogluconate dehydrogenase; The NAD binding domain of ...
19-99 2.25e-06

NAD binding domain of 6-phosphogluconate dehydrogenase; The NAD binding domain of 6-phosphogluconate dehydrogenase adopts a Rossmann fold.


Pssm-ID: 427298 [Multi-domain]  Cd Length: 159  Bit Score: 46.69  E-value: 2.25e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   19 KIAVVGYGSQGHAHAQNLKDNGYDVVIGIRPGRSFDKAKEDGFDVFP-VAEAVKQADVIMVLLPD-EIQGDVYKNE-IEP 95
Cdd:pfam03446   1 KIGFIGLGVMGSPMALNLLKAGYTVTVYNRTPEKVEELVAAGAIAAAsPAEFVAGLDVVITMVPAgAAVDAVIFGEgLLP 80

                  ....
gi 446136697   96 NLEK 99
Cdd:pfam03446  81 GLKP 84
COG2085 COG2085
Predicted dinucleotide-binding enzyme [General function prediction only];
20-81 4.04e-06

Predicted dinucleotide-binding enzyme [General function prediction only];


Pssm-ID: 441688 [Multi-domain]  Cd Length: 205  Bit Score: 46.70  E-value: 4.04e-06
                         10        20        30        40        50        60
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 446136697  20 IAVVGYGSQGHAHAQNLKDNGYDVVIGIR-PGRSFDKAKEDGFDV--FPVAEAVKQADVIMVLLP 81
Cdd:COG2085    1 IGIIGTGNIGSALARRLAAAGHEVVIGSRdPEKAAALAAELGPGAraGTNAEAAAAADVVVLAVP 65
PGDH_1 cd12155
Phosphoglycerate Dehydrogenase, 2-hydroxyacid dehydrogenase family; Phosphoglycerate ...
6-81 1.86e-05

Phosphoglycerate Dehydrogenase, 2-hydroxyacid dehydrogenase family; Phosphoglycerate Dehydrogenase (PGDH) catalyzes the NAD-dependent conversion of 3-phosphoglycerate into 3-phosphohydroxypyruvate, which is the first step in serine biosynthesis. Over-expression of PGDH has been implicated as supporting proliferation of certain breast cancers, while PGDH deficiency is linked to defects in mammalian central nervous system development. PGDH is a member of the 2-hydroxyacid dehydrogenase family, enzymes that catalyze the conversion of a wide variety of D-2-hydroxy acids to their corresponding keto acids. The general mechanism is (R)-lactate + acceptor to pyruvate + reduced acceptor. Formate/glycerate and related dehydrogenases of the D-specific 2-hydroxyacid dehydrogenase superfamily include groups such as formate dehydrogenase, glycerate dehydrogenase, L-alanine dehydrogenase, and S-Adenosylhomocysteine Hydrolase. Despite often low sequence identity, these proteins typically have a characteristic arrangement of 2 similar subdomains of the alpha/beta Rossmann-fold NAD+ binding form. The NAD+ binding domain is inserted within the linear sequence of the mostly N-terminal catalytic domain, which has a similar domain structure to the internal NAD binding domain. Structurally, these domains are connected by extended alpha helices and create a cleft in which NAD is bound, primarily to the C-terminal portion of the 2nd (internal) domain. Some related proteins have similar structural subdomain but with a tandem arrangement of the catalytic and NAD-binding subdomains in the linear sequence. While many members of this family are dimeric, alanine DH is hexameric and phosphoglycerate DH is tetrameric.


Pssm-ID: 240632 [Multi-domain]  Cd Length: 314  Bit Score: 45.65  E-value: 1.86e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   6 YDQDVKTDALQGKKIAVVGYGSQGHAHAQNLKdnGYDV-VIGI-RPGRsfdkaKEDGFD-VFP---VAEAVKQADVIMVL 79
Cdd:cd12155  124 WKMDSSLLELYGKTILFLGTGSIGQEIAKRLK--AFGMkVIGVnTSGR-----DVEYFDkCYPleeLDEVLKEADIVVNV 196

                 ..
gi 446136697  80 LP 81
Cdd:cd12155  197 LP 198
2-Hacid_dh_6 cd12165
Putative D-isomer specific 2-hydroxyacid dehydrogenases; 2-Hydroxyacid dehydrogenases catalyze ...
4-81 2.64e-05

Putative D-isomer specific 2-hydroxyacid dehydrogenases; 2-Hydroxyacid dehydrogenases catalyze the conversion of a wide variety of D-2-hydroxy acids to their corresponding keto acids. The general mechanism is (R)-lactate + acceptor to pyruvate + reduced acceptor. Formate/glycerate and related dehydrogenases of the D-specific 2-hydroxyacid dehydrogenase superfamily include groups such as formate dehydrogenase, glycerate dehydrogenase, L-alanine dehydrogenase, and S-adenosylhomocysteine hydrolase. Despite often low sequence identity, these proteins typically have a characteristic arrangement of 2 similar subdomains of the alpha/beta Rossmann fold NAD+ binding form. The NAD+ binding domain is inserted within the linear sequence of the mostly N-terminal catalytic domain, which has a similar domain structure to the internal NAD binding domain. Structurally, these domains are connected by extended alpha helices and create a cleft in which NAD is bound, primarily to the C-terminal portion of the 2nd (internal) domain. Some related proteins have similar structural subdomain but with a tandem arrangement of the catalytic and NAD-binding subdomains in the linear sequence. While many members of this family are dimeric, alanine DH is hexameric and phosphoglycerate DH is tetrameric.


Pssm-ID: 240642 [Multi-domain]  Cd Length: 314  Bit Score: 45.31  E-value: 2.64e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697   4 VYYDQDVK-------------TDALQGKKIAVVGYGSQGHAHAQNLKdnGYDV-VIGIRpgRSFDKAKEDGFdVFPVA-- 67
Cdd:cd12165  111 VEYDNDLRrgiwhgrageepeSKELRGKTVGILGYGHIGREIARLLK--AFGMrVIGVS--RSPKEDEGADF-VGTLSdl 185
                         90
                 ....*....|....*
gi 446136697  68 -EAVKQADVIMVLLP 81
Cdd:cd12165  186 dEALEQADVVVVALP 200
MmsB COG2084
3-hydroxyisobutyrate dehydrogenase or related beta-hydroxyacid dehydrogenase [Lipid transport ...
18-82 2.90e-05

3-hydroxyisobutyrate dehydrogenase or related beta-hydroxyacid dehydrogenase [Lipid transport and metabolism];


Pssm-ID: 441687 [Multi-domain]  Cd Length: 285  Bit Score: 45.11  E-value: 2.90e-05
                         10        20        30        40        50        60
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 446136697  18 KKIAVVGYGSQGHAHAQNLKDNGYDVVI-GIRPGRSfDKAKEDGFDVFP-VAEAVKQADVIMVLLPD 82
Cdd:COG2084    2 MKVGFIGLGAMGAPMARNLLKAGHEVTVwNRTPAKA-EALVAAGARVAAsPAEAAAAADVVITMLPD 67
2-Hacid_dh_C pfam02826
D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain; This domain is inserted ...
15-81 3.48e-05

D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain; This domain is inserted into the catalytic domain, the large dehydrogenase and D-lactate dehydrogenase families in SCOP. N-terminal portion of which is represented by family pfam00389.


Pssm-ID: 427007 [Multi-domain]  Cd Length: 178  Bit Score: 43.64  E-value: 3.48e-05
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 446136697   15 LQGKKIAVVGYGSQGHAHAQNLKdnGYDV-VIGIRP-GRSFDKAKEDGFDVFPVAEAVKQADVIMVLLP 81
Cdd:pfam02826  34 LSGKTVGIIGLGRIGRAVAKRLK--AFGMkVIAYDRyPKPEEEEEELGARYVSLDELLAESDVVSLHLP 100
AdoHcyase_NAD smart00997
S-adenosyl-L-homocysteine hydrolase, NAD binding domain;
15-76 2.49e-04

S-adenosyl-L-homocysteine hydrolase, NAD binding domain;


Pssm-ID: 198065 [Multi-domain]  Cd Length: 162  Bit Score: 40.90  E-value: 2.49e-04
                           10        20        30        40        50        60
                   ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 446136697    15 LQGKKIAVVGYGSQGHAHAQNLKDNGYDV-VIGIRPGRSFdKAKEDGFDVFPVAEAVKQADVI 76
Cdd:smart00997  21 LAGKNVVVAGYGDVGKGVAARLRGLGARViVTEIDPIRAL-EAAMDGFEVMKMEEAAKRADIF 82
2-Hacid_dh_7 cd12166
Putative D-isomer specific 2-hydroxyacid dehydrogenases; 2-Hydroxyacid dehydrogenases catalyze ...
12-81 3.58e-04

Putative D-isomer specific 2-hydroxyacid dehydrogenases; 2-Hydroxyacid dehydrogenases catalyze the conversion of a wide variety of D-2-hydroxy acids to their corresponding keto acids. The general mechanism is (R)-lactate + acceptor to pyruvate + reduced acceptor. Formate/glycerate and related dehydrogenases of the D-specific 2-hydroxyacid dehydrogenase superfamily include groups such as formate dehydrogenase, glycerate dehydrogenase, L-alanine dehydrogenase, and S-adenosylhomocysteine hydrolase. Despite often low sequence identity, these proteins typically have a characteristic arrangement of 2 similar subdomains of the alpha/beta Rossmann fold NAD+ binding form. The NAD+ binding domain is inserted within the linear sequence of the mostly N-terminal catalytic domain, which has a similar domain structure to the internal NAD binding domain. Structurally, these domains are connected by extended alpha helices and create a cleft in which NAD is bound, primarily to the C-terminal portion of the 2nd (internal) domain. Some related proteins have similar structural subdomain but with a tandem arrangement of the catalytic and NAD-binding subdomains in the linear sequence. While many members of this family are dimeric, alanine DH is hexameric and phosphoglycerate DH is tetrameric.


Pssm-ID: 240643 [Multi-domain]  Cd Length: 300  Bit Score: 41.81  E-value: 3.58e-04
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 446136697  12 TDALQGKKIAVVGYGSQGHAHAQNLKdnGYDVVIgIRPGRSfdkAKeDGFDVFPVAEA---VKQADVIMVLLP 81
Cdd:cd12166  127 TPSLADRRVLIVGYGSIGRAIERRLA--PFEVRV-TRVART---AR-PGEQVHGIDELpalLPEADVVVLIVP 192
SAHH cd00401
S-Adenosylhomocysteine Hydrolase, NAD-binding and catalytic domains; S-adenosyl-L-homocysteine ...
17-75 6.12e-04

S-Adenosylhomocysteine Hydrolase, NAD-binding and catalytic domains; S-adenosyl-L-homocysteine hydrolase (SAHH, AdoHycase) catalyzes the hydrolysis of S-adenosyl-L-homocysteine (AdoHyc) to form adenosine (Ado) and homocysteine (Hcy). The equilibrium lies far on the side of AdoHyc synthesis, but in nature the removal of Ado and Hyc is sufficiently fast, so that the net reaction is in the direction of hydrolysis. Since AdoHyc is a potent inhibitor of S-adenosyl-L-methionine dependent methyltransferases, AdoHycase plays a critical role in the modulation of the activity of various methyltransferases. The enzyme forms homotetramers, with each monomer binding one molecule of NAD+.


Pssm-ID: 240619 [Multi-domain]  Cd Length: 402  Bit Score: 41.29  E-value: 6.12e-04
                         10        20        30        40        50        60
                 ....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  17 GKKIAVVGYGSQGHAHAQNLKDNGYDVVIG-IRPGRSFdKAKEDGFDVFPVAEAVKQADV 75
Cdd:cd00401  195 GKVVVVAGYGWVGKGCAMRARGLGARVIVTeVDPICAL-QAAMDGFEVMPMEEAAKIGDI 253
2-Hacid_dh_11 cd12175
Putative D-isomer specific 2-hydroxyacid dehydrogenases, NAD-binding and catalytic domains; ...
14-81 1.33e-03

Putative D-isomer specific 2-hydroxyacid dehydrogenases, NAD-binding and catalytic domains; 2-Hydroxyacid dehydrogenases catalyze the conversion of a wide variety of D-2-hydroxy acids to their corresponding keto acids. The general mechanism is (R)-lactate + acceptor to pyruvate + reduced acceptor. Formate/glycerate and related dehydrogenases of the D-specific 2-hydroxyacid dehydrogenase superfamily include groups such as formate dehydrogenase, glycerate dehydrogenase, L-alanine dehydrogenase, and S-adenosylhomocysteine hydrolase. Despite often low sequence identity, these proteins typically have a characteristic arrangement of 2 similar subdomains of the alpha/beta Rossmann fold NAD+ binding form. The NAD+ binding domain is inserted within the linear sequence of the mostly N-terminal catalytic domain, which has a similar domain structure to the internal NAD binding domain. Structurally, these domains are connected by extended alpha helices and create a cleft in which NAD is bound, primarily to the C-terminal portion of the 2nd (internal) domain. Some related proteins have similar structural subdomain but with a tandem arrangement of the catalytic and NAD-binding subdomains in the linear sequence. While many members of this family are dimeric, alanine DH is hexameric and phosphoglycerate DH is tetrameric.


Pssm-ID: 240652 [Multi-domain]  Cd Length: 311  Bit Score: 39.86  E-value: 1.33e-03
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 446136697  14 ALQGKKIAVVGYGSQGHAHAQNLKdnGYDV-VIGIRPgRSFDKAKEDGFDVFPVA--EAVKQADVIMVLLP 81
Cdd:cd12175  139 ELSGKTVGIVGLGNIGRAVARRLR--GFGVeVIYYDR-FRDPEAEEKDLGVRYVEldELLAESDVVSLHVP 206
2-Hacid_dh_1 cd05300
Putative D-isomer specific 2-hydroxyacid dehydrogenase; 2-Hydroxyacid dehydrogenases catalyze ...
15-81 1.37e-03

Putative D-isomer specific 2-hydroxyacid dehydrogenase; 2-Hydroxyacid dehydrogenases catalyze the conversion of a wide variety of D-2-hydroxy acids to their corresponding keto acids. The general mechanism is (R)-lactate + acceptor to pyruvate + reduced acceptor. Formate/glycerate and related dehydrogenases of the D-specific 2-hydroxyacid dehydrogenase superfamily include groups such as formate dehydrogenase, glycerate dehydrogenase, L-alanine dehydrogenase, and S-adenosylhomocysteine hydrolase. Despite often low sequence identity, these proteins typically have a characteristic arrangement of 2 similar subdomains of the alpha/beta Rossmann fold NAD+ binding form. The NAD+ binding domain is inserted within the linear sequence of the mostly N-terminal catalytic domain, which has a similar domain structure to the internal NAD binding domain. Structurally, these domains are connected by extended alpha helices and create a cleft in which NAD is bound, primarily to the C-terminal portion of the 2nd (internal) domain. Some related proteins have similar structural subdomains but with a tandem arrangement of the catalytic and NAD-binding subdomains in the linear sequence. While many members of this family are dimeric, alanine DH is hexameric and phosphoglycerate DH is tetrameric. Formate dehydrogenase (FDH) catalyzes the NAD+-dependent oxidation of formate ion to carbon dioxide with the concomitant reduction of NAD+ to NADH. FDHs of this family contain no metal ions or prosthetic groups. Catalysis occurs though direct transfer of the hydride ion to NAD+ without the stages of acid-base catalysis typically found in related dehydrogenases. FDHs are found in all methylotrophic microorganisms in energy production and in the stress responses of plants.


Pssm-ID: 240625 [Multi-domain]  Cd Length: 313  Bit Score: 39.81  E-value: 1.37e-03
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446136697  15 LQGKKIAVVGYGSQGHAHAQNLKDNGYDvVIGIRpgRSFDKAKEDGFDVFP---VAEAVKQADVIMVLLP 81
Cdd:cd05300  132 LAGKTVLIVGLGDIGREIARRAKAFGMR-VIGVR--RSGRPAPPVVDEVYTpdeLDELLPEADYVVNALP 198
NAD_bind_Leu_Phe_Val_DH cd01075
NAD(P) binding domain of leucine dehydrogenase, phenylalanine dehydrogenase, and valine ...
11-75 1.62e-03

NAD(P) binding domain of leucine dehydrogenase, phenylalanine dehydrogenase, and valine dehydrogenase; Amino acid dehydrogenase (DH) is a widely distributed family of enzymes that catalyzes the oxidative deamination of an amino acid to its keto acid and ammonia with concomitant reduction of NADP+. For example, leucine DH catalyzes the reversible oxidative deamination of L-leucine and several other straight or branched chain amino acids to the corresponding 2-oxoacid derivative. Amino acid DH -like NAD(P)-binding domains are members of the Rossmann fold superfamily and include glutamate, leucine, and phenylalanine DHs, methylene tetrahydrofolate DH, methylene-tetrahydromethanopterin DH, methylene-tetrahydropholate DH/cyclohydrolase, Shikimate DH-like proteins, malate oxidoreductases, and glutamyl tRNA reductase. Amino acid DHs catalyze the deamination of amino acids to keto acids with NAD(P)+ as a cofactor. The NAD(P)-binding Rossmann fold superfamily includes a wide variety of protein families including NAD(P)- binding domains of alcohol DHs, tyrosine-dependent oxidoreductases, glyceraldehyde-3-phosphate DH, lactate/malate DHs, formate/glycerate DHs, siroheme synthases, 6-phosphogluconate DH, amino acid DHs, repressor rex, NAD-binding potassium channel domain, CoA-binding, and ornithine cyclodeaminase-like domains. These domains have an alpha-beta-alpha configuration. NAD binding involves numerous hydrogen and van der Waals contacts.


Pssm-ID: 133444  Cd Length: 200  Bit Score: 39.11  E-value: 1.62e-03
                         10        20        30        40        50        60
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 446136697  11 KTDALQGKKIAVVGYGSQGHAHAQNLKDNGYDVVIG-IRPGRSFDKAKEDGFDVFPVAEAVKQ-ADV 75
Cdd:cd01075   22 GTDSLEGKTVAVQGLGKVGYKLAEHLLEEGAKLIVAdINEEAVARAAELFGATVVAPEEIYSVdADV 88
PRK05476 PRK05476
S-adenosyl-L-homocysteine hydrolase; Provisional
17-76 1.82e-03

S-adenosyl-L-homocysteine hydrolase; Provisional


Pssm-ID: 235488 [Multi-domain]  Cd Length: 425  Bit Score: 39.72  E-value: 1.82e-03
                         10        20        30        40        50        60
                 ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 446136697  17 GKKIAVVGYGSQGHAHAQNLKDNGYDVVIG-IRPGRSFdKAKEDGFDVFPVAEAVKQADVI 76
Cdd:PRK05476 212 GKVVVVAGYGDVGKGCAQRLRGLGARVIVTeVDPICAL-QAAMDGFRVMTMEEAAELGDIF 271
formate_dh_like cd05198
Formate/glycerate and related dehydrogenases of the D-specific 2-hydroxy acid dehydrogenase ...
15-81 3.86e-03

Formate/glycerate and related dehydrogenases of the D-specific 2-hydroxy acid dehydrogenase family; Formate dehydrogenase, D-specific 2-hydroxy acid dehydrogenase, Phosphoglycerate Dehydrogenase, Lactate dehydrogenase, Thermostable Phosphite Dehydrogenase, and Hydroxy(phenyl)pyruvate reductase, among others, share a characteristic arrangement of 2 similar subdomains of the alpha/beta Rossmann fold NAD+ binding form. 2-hydroxyacid dehydrogenases are enzymes that catalyze the conversion of a wide variety of D-2-hydroxy acids to their corresponding keto acids. The general mechanism is (R)-lactate + acceptor to pyruvate + reduced acceptor. The NAD+ binding domain is inserted within the linear sequence of the mostly N-terminal catalytic domain, which has a similar domain structure to the internal NAD binding domain. Structurally, these domains are connected by extended alpha helices and create a cleft in which NAD is bound, primarily to the C-terminal portion of the 2nd (internal) domain. Some related proteins have similar structural subdomain but with a tandem arrangement of the catalytic and NAD-binding subdomains in the linear sequence. Formate dehydrogenase (FDH) catalyzes the NAD+-dependent oxidation of formate ion to carbon dioxide with the concomitant reduction of NAD+ to NADH. FDHs of this family contain no metal ions or prosthetic groups. Catalysis occurs though direct transfer of hydride ion to NAD+ without the stages of acid-base catalysis typically found in related dehydrogenases. FDHs are found in all methylotrophic microorganisms in energy production and in the stress responses of plants. Formate/glycerate and related dehydrogenases of the D-specific 2-hydroxyacid dehydrogenase superfamily include groups such as formate dehydrogenase, glycerate dehydrogenase, L-alanine dehydrogenase, and S-Adenosylhomocysteine Hydrolase, among others. While many members of this family are dimeric, alanine DH is hexameric and phosphoglycerate DH is tetrameric.


Pssm-ID: 240622 [Multi-domain]  Cd Length: 302  Bit Score: 38.38  E-value: 3.86e-03
                         10        20        30        40        50        60
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 446136697  15 LQGKKIAVVGYGSQGHAHAQNLKdnGYDV-VIGIRPGRSFDKAKEDGFDVFPVAEAVKQADVIMVLLP 81
Cdd:cd05198  138 LEGKTVGIVGLGRIGQRVAKRLQ--AFGMkVLYYDRTRKPEPEEDLGFRVVSLDELLAQSDVVVLHLP 203
F420_oxidored pfam03807
NADP oxidoreductase coenzyme F420-dependent;
21-81 5.07e-03

NADP oxidoreductase coenzyme F420-dependent;


Pssm-ID: 397743 [Multi-domain]  Cd Length: 92  Bit Score: 35.67  E-value: 5.07e-03
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 446136697   21 AVVGYGSQGHAHA-QNLKDNGYDVVIGIRPG--RSFDKAKEDGFDVFPV--AEAVKQADVIMVLLP 81
Cdd:pfam03807   1 GFIGAGNMGEALArGLVAAGPHEVVVANSRNpeKAEELAEEYGVGATAVdnEEAAEEADVVFLAVK 66
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH